[PMID 19520980] VEGF Receptor-2 Variants Are Associated With Susceptibility to Stroke and Recurrence
[PMID 20471686] Association of Age-related Macular Degeneration with Polymorphisms in Vascular Endothelial Growth Factor and Its Receptor
[PMID 22182247] Potentially functional genetic variants in KDR gene as prognostic markers in patients with resected colorectal cancer
[PMID 22507619] Association and interaction between dietary pattern and VEGF receptor-2 (VEGFR2) gene polymorphisms on blood lipids in Chinese Malaysian and Japanese adults
[PMID 20019880] Polymorphisms in the VEGFA and VEGFR-2 genes and neovascular age-related macular degeneration.
[PMID 21191630] Genetic variations in VEGF and VEGFR2 and glioblastoma outcome.
[PMID 22274884] Association between genetic variations of vascular endothelial growth factor receptor 2 and glioma in the Chinese Han population.
[PMID 24623964] Candidate gene association study for diabetic retinopathy in Chinese patients with type 2 diabetes
[PMID 22491902] The interaction between the maternal BMI and angiogenic gene polymorphisms associates with the risk of spontaneous preterm birth.
[PMID 23102494] Vascular endothelial growth factor family gene polymorphisms in preeclampsia in Sinhalese women in Sri-Lanka.
[PMID 24652518] VEGFA and VEGFR2 gene polymorphisms and response to anti-vascular endothelial growth factor therapy: comparison of age-related macular degeneration treatments trials (CATT)
[PMID 25123269] Genetic variants in the KDR gene is associated with the prognosis of transarterial chemoembolization treated hepatocellular carcinoma
[PMID 25128838] Minor association of kinase insert domain-containing receptor gene polymorphism (rs2071559) with myocardial infarction in Caucasians with type 2 diabetes mellitus: Case-control cross-sectional study
[PMID 26081139] Genetic Variations of Kinase Inserts Domain Receptor (KDR) Gene Are Associated with the Risk of Astrocytomas
[PMID 25182707] The relationship of kinase insert domain receptor gene polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients treated with sorafenib